良性遊走性舌炎の治療法は？

What are the best treatments for benign migratory glossitis?

• Morteza Banakar

抄録

データソース PubMed, The Cochrane Library, Embase, Science Direct, Scopus, Web of Science, Google Scholar databases.研究選択 小児および成人における症候性良性移行性舌炎（BMG）の治療に関する英語研究を検討した。3人目のレビュアーは矛盾を解決するために利用可能であった。結果 総勢150名の患者を対象とした11件の研究がレビューに投稿された。大多数（8件）は非常に低質、1件は低質、1件は中等質、1件は高質であると考えられた。様々な治療法が採用されたが、最も一般的なものはトリアムシノロンアセトニド0.1％（n = 2）、タクロリムス外用薬0.1％（n = 2）、ジフェンヒドラミン外用薬（n = 2）、栄養補助食品（n = 2）であった。

Data sources PubMed, The Cochrane Library, Embase, Science Direct, Scopus, Web of Science and Google Scholar databases.Study selection English language studies reporting on treatment of symptomatic benign migratory glossitis (BMG) in children and adults were considered.Data extraction and synthesis Two reviewers independently selected studies with a single author extracting data subsequently verified by a second reviewer. A third reviewer was available to resolve discrepancies. A narrative summary of the findings was presented.Results Eleven studies involving a total of 150 patients contributed to the review. A majority (eight) were considered to be of very low quality, one of low quality, one of moderate quality and one of high quality. A range of treatments were employed, the most common being triamcinolone acetonide 0.1% (n = 2), topical tacrolimus 0.1% (n = 2), topical diphenhydramine (n = 2), and nutritional supplements (n = 2)Conclusions There is substantial heterogeneity in the available studies providing very low-quality evidence for the treatment of symptomatic benign migratory glossitis.